Eli Lilly and Company

A→Z catalog of Eli Lilly

A

• Alimta — Pemetrexed disodium — NSCLC, mesothelioma — 500 mg/m² IV q3w.

• Amyvid — Florbetapir F18 — PET imaging agent for β-amyloid plaques (Alzheimer’s diagnosis).

• **Atabecestat (legacy pipeline, not marketed)*.

• Axiron — Testosterone topical solution — Hypogonadism — 60 mg daily (discontinued in some markets).

B

• Basaglar — Insulin glargine biosimilar (with BI) — T1DM, T2DM — Basal insulin dosing.

• Baqsimi — Glucagon nasal powder — Severe hypoglycemia — 3 mg intranasal once.

• Byetta — Exenatide — T2DM — 5–10 mcg SC BID.

• Bydureon BCise — Exenatide ER — T2DM — 2 mg SC weekly.

C

• Cialis — Tadalafil — Erectile dysfunction, BPH — 10–20 mg PRN or 5 mg daily.

• Cyramza — Ramucirumab — Gastric, NSCLC, CRC, HCC — IV infusion q2w.

• Cymbalta — Duloxetine — Depression, anxiety, neuropathic pain, fibromyalgia — 30–60 mg daily.

• Ceclor (legacy) — Cefaclor — Infections.

D

• Darzalex (co-promote in Japan with J&J).

• Dulaglutide (Trulicity) — see T.

• Demser — Metyrosine — Pheochromocytoma — 250 mg QID up to 4 g/day.

E

• Emgality — Galcanezumab — Migraine prevention, cluster headache — 240 mg SC loading, then 120 mg monthly.

• Erbitux (regional co-market, not Lilly global).

• Evista — Raloxifene — Osteoporosis prevention, breast cancer risk reduction — 60 mg daily.

F

• Forteo — Teriparatide — Osteoporosis — 20 mcg SC daily.

• Fluoxetine (Prozac) — see P.

G

• Glucagon Emergency Kit — Glucagon injection — Severe hypoglycemia — 1 mg SC/IM.

• Glucagon rDNA — Same as above.

H

• Humalog — Insulin lispro — T1DM, T2DM — Rapid-acting insulin.

• Humalog Mix 75/25, 50/50 — Biphasic premixes.

• Humulin R, N, 70/30 — Human insulin formulations.

I

• Insulin Lispro (Admelog biosimilar).

• Insulin Glargine (Basaglar) — see B.

• Insulin Lispro-aabc (Lyumjev) — Ultra-rapid insulin lispro — T1DM, T2DM — At mealtime.

• Insulin Degludec/Lispro (co-dev with BI, regional).

J

• Jardiance (co-market with BI) — Empagliflozin — T2DM, HF, CKD.

• Jentadueto (BI alliance) — Linagliptin + metformin.

K

• Kasina generics regional.

• Kinsun (regional).

L

• Lartruvo — Olaratumab — STS (withdrawn US/EU, still available regionally under access).

• Lyumjev — Insulin lispro-aabc — Ultra-rapid insulin.

• Loxo Oncology portfolio (acquired by Lilly):

  • Vitrakvi — Larotrectinib — TRK fusion-positive cancers — 100 mg BID.

  • Retevmo — Selpercatinib — RET fusion+ NSCLC, thyroid cancers — 120–160 mg BID.

  • Jaypirca — Pirtobrutinib — BTK inhibitor, CLL/SLL, MCL — 200 mg QD.

M

• Mounjaro — Tirzepatide — T2DM, obesity — Start 2.5 mg SC weekly → titrate to 15 mg.

• Methadone HCl (legacy supply in some regions).

• Methotrexate (oncology legacy).

N

• Nerivio (co-promote regional).

• Northera — Droxidopa — Neurogenic orthostatic hypotension — 100–600 mg TID.

O

• Olumiant — Baricitinib — RA, atopic dermatitis, alopecia areata, COVID-19 (short-term) — 2–4 mg daily.

• Omvoh — Mirikizumab — Ulcerative colitis, Crohn’s disease — IV induction, then SC 200 mg q4w.

• Oncology generics (cisplatin, gemcitabine regional).

P

• Prozac — Fluoxetine — Depression, OCD, bulimia, panic disorder — 20–80 mg daily.

• Paroxetine (regional generics by Lilly).

• Pirtobrutinib (Jaypirca) — see L.

Q

• Quinapril Lilly generics — Quinapril — Hypertension, HF.

R

• Raloxifene (Evista) — see E.

• Retevmo — see L.

S

• Strattera — Atomoxetine — ADHD — 40–100 mg daily.

• Symdeko (regional rights, Vertex).

T

• Taltz — Ixekizumab — Plaque psoriasis, PsA, axial spondyloarthritis — 160 mg SC load, then 80 mg q2–4w.

• Trulicity — Dulaglutide — T2DM, obesity — 0.75–4.5 mg SC weekly.

• Tirzepatide (Mounjaro, Zepbound) — see M/Z.

U

• Umurel (regional).

• UroXatral generics.

V

• Verzenio — Abemaciclib — HR+/HER2- breast cancer — 150 mg BID (combo or mono).

• Vibramycin legacy — Doxycycline.

• Vitrakvi — see L.

• Valproate (regional generics).

W

• Wynzora distribution.

X

• Xigris (withdrawn, sepsis drug, legacy).

• Xeljanz alliance rights (co-market in Japan historically).

Y

• Yentreve — Duloxetine (EU branding for stress urinary incontinence).

• Yuflyma (biosimilar alliances).

Z

• Zepbound — Tirzepatide — Obesity/weight management — 2.5–15 mg SC weekly.

• Zyprexa — Olanzapine — Schizophrenia, bipolar disorder — 5–20 mg daily.

• Zyprexa Relprevv — Olanzapine LAI — Monthly depot injection.